“The take-home message is that men being worked up for an elevated PSA [prostate-specific antigen] or an abnormal digital rectal examination who are at increased risk of prostate cancer may ...

The first patient in a phase 2 clinical trial evaluating 67Cu-SAR-bisPSMA for patients with metastatic castration-resistant ...

The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.

Neuroendocrine prostate cancer (NEPC) is the most aggressive form of prostate cancer, responsible for up to 20% of therapy-resistant cases and associated with rapid disease progression. It is ...

BOSTON — Solid intraductal carcinoma of the prostate (IDC-P) is associated with significantly worse outcomes compared with conventional Gleason grade 5 prostate cancers, and is more commonly ...

ALSO READ: 5 early signs of menopause women aged 35–45 shouldn’t ignore Prostate cancer is a disease in which abnormal cells ...

New data suggest that early integration of palliative care is increasingly being used in patients with advanced cancers, but use remains low overall.